DHDanni He

Danni He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Danni He has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Qi Zhang

    Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China

    2 shared publications
  • Bin Zhou

    Key Laboratory of Animal Microbiology of China’s Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China

    1 shared publication
  • Fan Li

    1 shared publication
  • Hengmei Shi

    Department of Obstetrics and Gynecology, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu, China

    1 shared publication
  • Huyang Hou

    Department of Obstetrics and Gynecology, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu, China

    1 shared publication
  • Jiaheng Xie

    Department of Plastic Surgery, Xiangya Hospital Central South University, Changsha, China.

    1 shared publication

Latest Publications

  • Open Access

    Plasma Bile Acid Profiling Reveals Novel Early Diagnostic Biomarkers for Pediatric Sepsis

    by Lipeng Zhang, Jing Liu, Yuanmei Chen, Xiuxiu Lu, Ke Li, Wei Li, Ning Li, Fan Li, Yuanyuan Wang, Danni He, et al.

    Sepsis is a life-threatening condition, and early detection remains a challenge. While bile acids have been implicated in various diseases, their role as biomarkers for sepsis is underexplored. This study aims to identify metabolites associated with sepsis and assess the potential of bile acids for early diagnosis and prognosis of pediatric sepsis. We enrolled 100 participants in the discovery phase and 141 participants in the validation phase. Non-targeted liquid chromatography-mass spectrometry (LC-MS) metabolomics analyses were performed to identify differential metabolites between sepsis patients and healthy controls. Targeted quantitative analysis of 12 plasma bile acids (BA) was conducted to assess their concentrations. Machine learning algorithms, including Recursive Feature Elimination (RFE), Least Absolute Shrinkage and Selection Operator (LASSO), Random Forest (RF), Support Vector Machine-RFE (SVM-RFE), and Gradient Boosting Decision Tree (GBDT), were employed to identify key BAs for sepsis diagnosis. Untargeted metabolomics revealed bile acid pathway dysregulation, validated by targeted quantification showing elevated primary bile acids—cholic acid (CA), glycocholic acid (GCA), taurocholic acid (TCA), glycochenodeoxycholic acid (GCDCA), taurochenodeoxycholic acid (TCDCA)—and taurine-conjugated secondary bile acid TDCA (p<0.05). Conversely, secondary bile acids deoxycholic acid (DCA), glycodeoxycholic acid (GDCA), ursodeoxycholic acid (UDCA), glycoursodeoxycholic acid (GUDCA), and lithocholic acid (LCA) were significantly reduced (p<0.05). Univariate logistic regression identified TCA, TDCA, GCA, TCDCA, GCDCA, and TDCA/DCA as risk factors for sepsis, while LCA, DCA, UDCA, GUDCA, and DCA/CA were protective factors. Five machine learning models identified four bile acid indicators—UDCA, GUDCA, GCA, DCA—as key predictors for sepsis diagnosis, with a combined model area under the curve (AUC) of 0.880. Additionally, DCA/CA and GCDCA were important predictors for septic shock, with risks increasing by 4.5% (OR = 1.045, 95% CI: 1.009–1.081) and 30% (OR = 0.700, 95% CI: 0.526–0.932), respectively. LCA was a risk factor for respiratory failure in sepsis, with an OR of 2.154 (95% CI: 1.022–4.540). Our results highlight the potential of bile acid profiling as a diagnostic and prognostic biomarker for pediatric sepsis. These findings suggest a path toward early intervention, improving patient outcomes by enabling timely detection and treatment.


  • Open Access

    Digging out the biology properties of tRNA-derived small RNA from black hole

    by Hengmei Shi, Jiaheng Xie, Shengbin Pei, Danni He, Huyang Hou, Shipeng Xu, Ziyi Fu, Xiaoyan Shi

    An unique subclass of functional non-coding RNAs generated by transfer RNA (tRNA) under stress circumstances is known as tRNA-derived small RNA (tsRNA). tsRNAs can be divided into tRNA halves and tRNA-derived fragments (tRFs) based on the different cleavage sites. Like microRNAs, tsRNAs can attach to Argonaute (AGO) proteins to target downstream mRNA in a base pairing manner, which plays a role in rRNA processing, gene silencing, protein expression and viral infection. Notably, tsRNAs can also directly bind to protein and exhibit functions in transcription, protein modification, gene expression, protein stabilization, and signaling pathways. tsRNAs can control the expression of tumor suppressor genes and participate in the initiation of cancer. It can also mediate the progression of diseases by regulating cell viability, migration ability, inflammatory factor content and autophagy ability. Precision medicine targeting tsRNAs and drug therapy of plant-derived tsRNAs are expected to be used in clinical practice. In addition, liquid biopsy technology based on tsRNAs indicates a new direction for the non-invasive diagnosis of diseases.


  • Open Access

    Important Concerns Over SARS-CoV-2 Infection in Children With Cancer

    by Lipeng Zhang, Danni He, Wenquan Niu

    To the Editor We read with great interest the Research Letter by Boulad et al that reports a low morbidity of coronavirus disease 2019 (COVID-19) in pediatric p

  • Open Access

    Additional Concerns Regarding Children With Coronavirus Disease 2019

    by Danni He, Qi Zhang

    To the Editor We read with great interest the study by Castagnoli et al that shows milder symptoms, better prognosis, and less severe conditions in children wit

  • In vitro inhibition of Japanese encephalitis virus replication by capsid-targeted virus inactivation

    by Ran Pang, Dan-Ni He, Bin Zhou, Ke Liu, Jin Zhao, Xiao-Min Zhang, Pu-Yan Chen